Publications

2009

Arora N, Scognamiglio T, Lubitz CC, Moo TA, Kato MA, Zhu B, et al. Identification of borderline thyroid tumors by gene expression array analysis. Cancer. 2009;115(23):5421-31.
Moscat J, Diaz-Meco MT. To aggregate or not to aggregate? A new role for p62. EMBO Rep. 2009;10(8):804.
Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 2009;69(8):3364-73.
Kartono F, Shitabata PK, Magro CM, Rayhan D. Discohesive malignant melanoma simulating a bullous dermatoses. J Cutan Pathol. 2009;36(2):274-9.
Das C, M Lucia S, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature. 2009;459(7243):113-7.
Solomon JP, Yonemoto IT, Murray AN, Price JL, Powers ET, Balch WE, et al. The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic. Biochemistry. 2009;48(48):11370-80.
Mosunjac M, Park J, Wang W, Tadros T, Siddiqui M, Bagirov M, et al. Genital and perianal herpes simplex simulating neoplasia in patients with AIDS. AIDS Patient Care STDS. 2009;23(3):153-8.
Chen C-, Tyler J. Selective sensitization of cancer cells to DNA damage by a HAT inhibitor. Cell Cycle. 2009;8(18):2867.
Fernandez-Marcos PJ, Abu-Baker S, Joshi J, Galvez A, Castilla EA, Cañamero M, et al. Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma. Proc Natl Acad Sci U S A. 2009;106(31):12962-7.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700